Pfizer Announces Plan to Trim Haleon Stake with £2 Billion Share Sale
Monday, 18 March 2024, 10:38
Pfizer to Reduce Stake in Haleon Through Share Sale
Pfizer has announced its decision to lower its ownership in Haleon by conducting a secondary offering, while Haleon agrees to repurchase shares from Pfizer off-market. This strategic move signals a shift in Pfizer's investment strategy and may influence the market dynamics for both companies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.